Latest filing published 24 Jun 2026 for BridgeBio Pharma, Inc..
Filing timeline
BuySaleInsider track record
Frank Mccormick: trading record in brief
Frank Mccormick has filed trades across 2 companies (mainly through SEC (Form 4)), most often in BridgeBio Pharma, Inc. and Olema Pharmaceuticals, Inc. The record holds 38 filings, for trades running from 1 July 2019 to 22 June 2026.
Sales make up the whole of the open-market record (22 sales, €29.4M). Besides market trades, the filings include 3 share grants and 7 option exercises.
The latest filing, published on 24 June 2026, reports a share grant in BridgeBio Pharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Frank Mccormick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,990 sharesCommon StockSEC:0001470831-26-000627:0
- 111,755 shares@ US$65.476442.6% of flowCommon StockSEC:0001470831-25-000282:0
- 1,641 shares@ US$65.000.6% of flowCommon StockSEC:0001470831-25-000278:0
- 74,000 shares@ US$11.925.1% of flowCommon StockSEC:0001257809-25-000003:0
- 100,000 shares@ US$44.22825.8% of flowCommon StockSEC:0000950170-25-090498:0
- 6,589 shares0Common StockSEC:0000950170-25-089669:0
- 33,000 shares0Common StockSEC:0000950170-25-068335:0
- 7,400 shares0Common StockSEC:0000950170-25-003541:0
- 7,400 shares0Common StockSEC:0000950170-24-140874:0
- 100,000 shares@ US$42.0625.9% of flowCommon StockSEC:0001209191-23-059885:0
10 of 10 declarations
